MSCI WORLD Stock

Index

Real-time MSCI 01:51:30 2024-06-03 am EDT			5-day change	1st Jan Change
3,448 ^USD	+0.07%		-0.04%	+8.71%

May. 24	Pantheon International spends GBP800,000 on buyback programme in April	AN
May. 24	Rate outlook weighs on equities

Duration

Period

Style

Pantheon International spends GBP800,000 on buyback programme in April	May. 24	AN
Rate outlook weighs on equities	May. 24
MORNING BID ASIA-As CPI risk clears ... it's lift off!	May. 15	RE
GLOBAL-MARKETS-Stocks jump, yields fall after cooler US consumer prices	May. 15	RE
Financials Gain as Sector Tests All-Time Highs - Financials Roundup	May. 10	DJ
The LSE braces for key economic data	Apr. 08
Momentum Picks Q2 2024: 5 stocks for spring	Apr. 02
Indices: Luxury loses its sparkle	Mar. 26
FTSE to slip as US data hits risk appetite	Mar. 15	AN
Global equity funds draw inflows of $6.5 bln on rate cut hopes	Mar. 08	RE
Tech rally, AI excitement drive strong inflows into global equity funds	Mar. 01	RE
Nikkei hits record high on Wall Street bounce, other Asian markets subdued	Feb. 29	RE
MORNING BID ASIA-Markets buoyant, but China PMIs await	Feb. 29	RE
Stocks stagnate as investors await US inflation data	Feb. 28	RE
EARNINGS: Smithson says net value up, Orcadian narrows operating loss	Feb. 27	AN

Revised Skydance offer would let Paramount shareholders cash out at $15/shr, WSJ reports 6758	Jun. 02	RE
Astra's Enhertu breast cancer trial shows 'unprecedented' results AZN	Jun. 02	RE
Revised Skydance offer gives Paramount shareholders opportunity to cash out at $15 a share, WSJ reports PARA	Jun. 02	RE
Revised Skydance Offer Gives Paramount Shareholders Opportunity To Cash Out At $15 A Share- WSJ PARA	Jun. 02	RE
TAGRISSO® (osimertinib) reduced the risk of disease progression or death by 84% in patients with unresectable, Stage III EGFR-mutated lung cancer vs. placebo in LAURA Phase III trial AZN	Jun. 02	BU
AstraZeneca : Tagrisso reduced the risk of disease progression or death by 84% in patients with unresectable, Stage III EGFR-mutated lung cancer vs. placebo in LAURA Phase III trial AZN	Jun. 02	PU
Europe needs to invest more in defence production, Airbus CEO says AIR	Jun. 02	RE
Nippon Steel's Mori returns to US this week for talks on US Steel takeover 5401	Jun. 02	RE
Emirates boss says Boeing needs strong CEO to end crisis BA	Jun. 02	RE
Astra's Enhertu delays breast cancer in patients with low HER2 levels AZN	Jun. 02	RE

No results for this search

Les Bourses mondiales indécises après des indicateurs d'inflation	May. 31
Les Bourses mondiales attendent des chiffres d'inflation	May. 31
Les Bourses mondiales en ordre dispersé, perplexes sur la trajectoire des taux	May. 30
Les Bourses mondiales divisées avant des données sur l'inflation	May. 30
Les Bourses mondiales prises en étau entre hausse des taux et attente de données	May. 30

Name	5d. change	AuM	Geo-Target	Theme	Asset Class
JPMORGAN EQUITY PREMIUM INCOME ETF - USD	-0.16%	30,811 M€	United States	-	Equities
DIMENSIONAL U.S. CORE EQUITY 2 ETF - USD	+0.57%	24,698 M€	United States	-	Equities
JPMORGAN ULTRA-SHORT INCOME ETF - DISTRIBUTING - USD	+0.12%	21,500 M€	United States	-	Fixed Income
JPMORGAN NASDAQ EQUITY PREMIUM INCOME ETF - USD	-0.04%	11,696 M€	United States	-	Equities
PIMCO ENHANCED SHORT MATURITY ACTIVE EXCHANGE-TRADED FUND - USD	+0.13%	11,106 M€	No restriction	-	Fixed Income
AVANTIS U.S. SMALL CAP VALUE ETF - USD	+2.04%	9,981 M€	United States	-	Equities
DIMENSIONAL US MARKETWIDE VALUE ETF - USD	+0.98%	9,557 M€	United States	-	Equities
DIMENSIONAL US TARGETED VALUE ETF - USD	+1.91%	8,865 M€	United States	-	Equities
FIDELITY TOTAL BOND ETF - USD	-0.25%	8,231 M€	United States	-	Fixed Income
DIMENSIONAL US EQUITY ETF - USD	+0.05%	8,171 M€	United States	-	Equities